Bial drug trial volunteer dies in France
- ZEEL combines 3D, virtual reality to develop technology platform Z5X
- ‘Badhaai Ho’ joins the list of 2018’s festive hits
- Malayalam cinema battles misogyny as #MeToo gains ground in other industries
- Why television has an edge over digital advertising platforms during festive season
- #MeToo takes a toll on Bollywood projects
Rennes, France: A man left brain dead after a drug trial in northwest France died on Sunday, said the hospital where he was being treated.
The Rennes hospital said in a statement that five other volunteers were in stable condition after they were admitted last week.
In total, 90 people took part in the trial of the drug made by Portuguese pharmaceutical company Bial, which is intended to treat mood and anxiety issues, as well as movement coordination disorders linked to neurological issues.
It was not yet known what caused the tragedy, said Francois Peaucelle, the head of Biotrial, the company that conducted the trials for Bial.
Cases of early-stage clinical trials going badly wrong are rare but not unheard of. In 2006, six healthy volunteers given an experimental drug in London ended up in intensive care. Reuters
Editor's Picks »
- IPG Mediabrands’ Initiative appoints Alok Sinha as chief strategy officer
- Mumbai airport runway to remain shut for 6 hours today, 300 flights may be hit
- India, others to pay the price for US-China trade war
- Sabarimala: Supreme Court to hear review petitions on 13 November
- SC refuses blanket ban on firecrackers, allows conditional sale ahead of Diwali